Microba Life Sciences Ltd (AU:MAP) — Stock Price
Microba Life Sciences Ltd (AU:MAP) is currently trading at AU$0.05 AUD, up 0.00% today. Over the past 52 weeks, shares have ranged between AU$0.04 and AU$0.10. This page tracks Microba Life Sciences Ltd's live share price on the AU exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Microba Life Sciences Ltd (MAP) market capitalisation.
Microba Life Sciences Ltd (MAP) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Microba Life Sciences Ltd's daily closing share price and trading volume on the AU exchange over the past year, giving a clear view of recent price momentum and liquidity.
Microba Life Sciences Ltd Income Statement — Revenue, Profit & Earnings by Year
Microba Life Sciences Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | AU$15.67 Million | AU$12.09 Million | AU$5.42 Million | AU$4.69 Million | AU$3.73 Million |
| Cost of Revenue | AU$8.23 Million | AU$6.18 Million | AU$12.19 Million | AU$2.32 Million | AU$9.04 Million |
| Gross Profit | AU$7.44 Million | AU$5.91 Million | AU$-6.77 Million | AU$2.37 Million | AU$-5.30 Million |
| Research & Development | AU$2.01 Million | AU$10.84 Million | AU$9.34 Million | AU$5.38 Million | AU$1.54 Million |
| SG&A | AU$16.95 Million | AU$12.18 Million | AU$7.81 Million | AU$8.57 Million | AU$821.98K |
| Total Operating Expenses | AU$32.05 Million | AU$32.75 Million | AU$13.45 Million | AU$8.52 Million | AU$4.27 Million |
| Operating Income | AU$-24.61 Million | AU$-26.84 Million | AU$-20.23 Million | AU$-16.27 Million | AU$-9.57 Million |
| EBITDA | AU$-10.51 Million | AU$-17.10 Million | AU$-17.07 Million | AU$-9.86 Million | AU$-6.28 Million |
| EBIT | AU$-14.94 Million | AU$-19.97 Million | AU$-18.71 Million | AU$-11.41 Million | AU$-7.50 Million |
| Interest Expense | AU$176.69K | AU$69.22K | AU$60.41K | AU$55.29K | AU$23.46K |
| Income Before Tax | AU$-15.05 Million | AU$-19.99 Million | AU$-18.77 Million | AU$-11.46 Million | AU$-7.52 Million |
| Income Tax Expense | AU$-106.59K | AU$-51.30K | AU$-6.09 Million | AU$9.23K | AU$1.00 |
| Net Income | AU$-14.94 Million | AU$-19.94 Million | AU$-12.68 Million | AU$-11.47 Million | AU$-7.52 Million |
Microba Life Sciences Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Microba Life Sciences Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | AU$47.44 Million | AU$58.04 Million | AU$46.95 Million | AU$39.48 Million | AU$18.49 Million |
| Total Current Assets | AU$19.00 Million | AU$32.25 Million | AU$41.53 Million | AU$35.82 Million | AU$16.22 Million |
| Cash & Equivalents | AU$2.71 Million | AU$4.21 Million | AU$12.43 Million | AU$204.44K | AU$50.30K |
| Short-term Investments | AU$138.64K | AU$204.44K | AU$204.44K | AU$204.44K | AU$50.30K |
| Net Receivables | AU$4.11 Million | AU$8.10 Million | AU$7.24 Million | AU$3.42 Million | AU$1.65 Million |
| Inventory | AU$1.94 Million | AU$2.24 Million | AU$644.43K | AU$360.03K | AU$513.28K |
| Property, Plant & Equipment | AU$3.87 Million | AU$3.91 Million | AU$2.58 Million | AU$2.81 Million | AU$1.20 Million |
| Goodwill | AU$10.02 Million | AU$8.45 Million | — | — | — |
| Total Liabilities | AU$14.94 Million | AU$16.82 Million | AU$8.23 Million | AU$5.94 Million | AU$3.55 Million |
| Total Current Liabilities | AU$10.17 Million | AU$12.37 Million | AU$7.82 Million | AU$5.26 Million | AU$3.35 Million |
| Long-term Debt | AU$468.69K | AU$0.00 | — | — | AU$0.00 |
| Net Debt | AU$-8.51 Million | AU$-19.31 Million | AU$-30.91 Million | AU$-29.26 Million | AU$-12.76 Million |
| Total Stockholder Equity | AU$32.49 Million | AU$41.22 Million | AU$38.57 Million | AU$33.54 Million | AU$14.94 Million |
| Retained Earnings | AU$-78.76 Million | AU$-63.82 Million | AU$-43.88 Million | AU$-31.20 Million | AU$-19.73 Million |
Microba Life Sciences Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Microba Life Sciences Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | AU$-12.01 Million | AU$-15.57 Million | AU$-12.39 Million | AU$-10.45 Million | AU$-7.18 Million |
| Capital Expenditures | AU$2.90 Million | AU$4.38 Million | AU$3.04 Million | AU$1.87 Million | AU$672.46K |
| Free Cash Flow | AU$-14.91 Million | AU$-19.95 Million | AU$-15.43 Million | AU$-1.87 Million | AU$-7.85 Million |
| Investing Cash Flow | AU$-2.83 Million | AU$-13.95 Million | AU$-3.00 Million | AU$-1.73 Million | AU$-522.48K |
| Financing Cash Flow | AU$5.58 Million | AU$18.39 Million | AU$16.68 Million | AU$29.22 Million | AU$13.84 Million |
| Dividends Paid | — | — | AU$595.63K | AU$425.35K | — |
| Stock-Based Compensation | — | — | AU$420.99K | AU$641.57K | AU$562.79K |
| Depreciation | — | AU$2.87 Million | AU$1.64 Million | AU$1.15 Million | AU$1.22 Million |
| Change in Cash | AU$-9.15 Million | AU$-11.15 Million | AU$1.46 Million | AU$17.60 Million | AU$6.13 Million |
Microba Life Sciences Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Microba Life Sciences Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 23, 2026 | 0.00 | 0.00 | — |
| Mar 04, 2026 | 0.00 | 0.00 | — |
| Oct 27, 2025 | 0.00 | 0.00 | — |
| Aug 26, 2025 | -0.02 | 0.00 | — |
| Apr 17, 2025 | 0.00 | 0.00 | — |
| Feb 25, 2025 | -0.01 | 0.00 | — |
| Oct 28, 2024 | 0.00 | 0.00 | — |
| Aug 28, 2024 | 0.00 | 0.00 | — |